Loading clinical trials...
Loading clinical trials...
A New Natural Origin Product, Achieving More Than 80% Efficiency in Spermatogenesis in the Seminiferous Tubules. This Method Opens up Hope for Cases of Infertility Caused by the Inability of Spermatogonia to Develop Into Mature Sperm.
Conditions
Interventions
FPT-20
Locations
2
United States
Saigon Biopharma LLC
Wilmington, Delaware, United States
Saigon Biopharma Company Limited
Hồ Chí Minh, Ho Chi Minh City, Vietnam
Start Date
October 29, 2020
Primary Completion Date
May 20, 2022
Completion Date
May 20, 2022
Last Updated
May 16, 2025
NCT05951075
NCT03414164
Lead Sponsor
Trieu, Nguyen Thi, M.D.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions